Merck & Co Inc logo

Merck & Co Inc - Cedear

BUE:MRK (USA)   Cedear
ARS 17000.50 (+0.08%) Oct 2
On watch
P/E:
83.78
P/B:
6.71
Market Cap:
ARS 91.48T ($ 261.38B)
Enterprise V:
ARS 102.22T ($ 292.04B)
Volume:
277.00
Avg Vol (2M):
551.00
Also Trade In:
Volume:
277.00
Market Cap ARS:
91.48T
Market Cap $:
261.38B
PE Ratio:
83.78
Avg Vol (2M):
551.00
Enterprise Value ARS:
102.22T
Enterprise Value $:
292.04B
PB Ratio:
6.71

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2023-10-27 Est.)

BUE:MRK's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 10,867,459.343
EPS (TTM) (ARS) 309.635
Beta 0
Volatility % 43.57
14-Day RSI 68.97
14-Day ATR (ARS) 381.376842
20-Day SMA (ARS) 16201.575
12-1 Month Momentum % 212.31
52-Week Range (ARS) 5310 - 17844
Shares Outstanding (Mil) 253.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price(ARS)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(BUE:MRK)'s stock price today?
The current price of BUE:MRK is ARS17000.50. The 52 week high of BUE:MRK is ARS17844.00 and 52 week low is ARS5310.00.
When is next earnings date of Merck & Co Inc(BUE:MRK)?
The next earnings date of Merck & Co Inc(BUE:MRK) is 2023-10-27 Est..
Does Merck & Co Inc(BUE:MRK) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(BUE:MRK) is 0.86% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(BUE:MRK) was 2.17. The lowest was 0.05. And the median was 1.09. The  Forward Dividend Yield % of Merck & Co Inc(BUE:MRK) is 1.2%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release